IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,051,225 | -15.0% | 1,830,575 | +1.1% | 0.01% | -20.0% |
| Q2 2023 | $34,163,418 | +470.7% | 1,810,462 | +16.1% | 0.01% | +400.0% |
| Q1 2023 | $5,986,641 | -22.7% | 1,559,021 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $7,745,457 | +6.2% | 1,561,584 | +2.4% | 0.00% | -33.3% |
| Q3 2022 | $7,291,000 | +10.7% | 1,525,106 | +4.2% | 0.00% | +50.0% |
| Q2 2022 | $6,589,000 | -7.7% | 1,464,219 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $7,142,000 | -32.3% | 1,500,219 | +5.5% | 0.00% | -33.3% |
| Q4 2021 | $10,551,000 | +32.3% | 1,421,923 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $7,973,000 | -17.3% | 1,406,002 | -3.8% | 0.00% | 0.0% |
| Q2 2021 | $9,637,000 | -17.2% | 1,462,235 | +1.7% | 0.00% | -25.0% |
| Q1 2021 | $11,645,000 | +47.1% | 1,437,600 | +17.1% | 0.00% | +33.3% |
| Q4 2020 | $7,919,000 | +93.0% | 1,227,636 | +7.7% | 0.00% | +50.0% |
| Q3 2020 | $4,104,000 | -23.1% | 1,139,973 | -1.7% | 0.00% | -33.3% |
| Q2 2020 | $5,337,000 | +45.6% | 1,160,095 | +7.9% | 0.00% | +50.0% |
| Q1 2020 | $3,666,000 | -20.5% | 1,074,940 | +19.0% | 0.00% | 0.0% |
| Q4 2019 | $4,613,000 | +115.5% | 903,495 | +2.1% | 0.00% | +100.0% |
| Q3 2019 | $2,141,000 | +14.9% | 884,585 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $1,863,000 | -17.6% | 858,363 | +2.9% | 0.00% | 0.0% |
| Q1 2019 | $2,262,000 | -44.1% | 834,401 | -1.1% | 0.00% | -66.7% |
| Q4 2018 | $4,049,000 | -51.0% | 843,417 | -3.3% | 0.00% | -40.0% |
| Q3 2018 | $8,257,000 | +10.8% | 871,837 | +13.8% | 0.01% | 0.0% |
| Q2 2018 | $7,453,000 | +33.4% | 765,956 | +44.2% | 0.01% | +25.0% |
| Q1 2018 | $5,587,000 | +66.6% | 531,076 | +1.6% | 0.00% | +33.3% |
| Q4 2017 | $3,353,000 | -0.7% | 522,964 | +18.5% | 0.00% | 0.0% |
| Q3 2017 | $3,378,000 | +43.1% | 441,445 | +33.0% | 0.00% | +50.0% |
| Q2 2017 | $2,360,000 | +84.7% | 331,898 | +0.6% | 0.00% | +100.0% |
| Q1 2017 | $1,278,000 | +57.0% | 329,979 | -17.3% | 0.00% | 0.0% |
| Q4 2016 | $814,000 | -21.9% | 398,768 | +2.6% | 0.00% | 0.0% |
| Q3 2016 | $1,042,000 | +12.4% | 388,604 | +29.1% | 0.00% | 0.0% |
| Q2 2016 | $927,000 | -63.1% | 300,956 | +2.0% | 0.00% | -66.7% |
| Q1 2016 | $2,515,000 | -36.3% | 295,082 | +1.4% | 0.00% | -40.0% |
| Q4 2015 | $3,949,000 | +36.6% | 290,999 | -3.3% | 0.01% | +25.0% |
| Q3 2015 | $2,891,000 | -29.0% | 301,062 | +6.3% | 0.00% | -33.3% |
| Q2 2015 | $4,074,000 | +65.5% | 283,281 | +3.1% | 0.01% | +100.0% |
| Q1 2015 | $2,461,000 | +54.1% | 274,861 | +5.0% | 0.00% | +50.0% |
| Q4 2014 | $1,597,000 | -34.0% | 261,655 | +14.5% | 0.00% | -50.0% |
| Q3 2014 | $2,420,000 | -12.1% | 228,465 | -1.6% | 0.00% | -20.0% |
| Q2 2014 | $2,752,000 | -20.9% | 232,205 | -0.4% | 0.01% | -16.7% |
| Q1 2014 | $3,480,000 | +7.7% | 233,055 | +5.8% | 0.01% | 0.0% |
| Q4 2013 | $3,231,000 | -7.4% | 220,224 | +9.4% | 0.01% | -14.3% |
| Q3 2013 | $3,490,000 | +5.2% | 201,237 | +4.3% | 0.01% | 0.0% |
| Q2 2013 | $3,316,000 | – | 192,855 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |